Barton Russell 4
4 · Acumen Pharmaceuticals, Inc. · Filed Jan 21, 2022
Insider Transaction Report
Form 4
Barton Russell
Chief Operating Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-01-19+135,000→ 135,000 totalExercise: $5.19Exp: 2032-01-19→ Common Stock (135,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on January 19, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest and become exercisable each month thereafter, subject to Reporting Person continuing to provide service through each such date.